BCL-w level was higher in paclitaxel-resistant than in paclitaxel-sensitive non-small cell lung cancer cells, and miR-107-dependent downregulation of BCL-w sensitized resistant cells to the drug110. Here, BCL2L2 is linked to non-small cell lung carcinoma.